May 8 Valeant
* Bausch + Lomb announces PDUFA date for new OTC redness reliever, brimonidine tartrate ophthalmic solution, 0.025%
* U.S. FDA accepted NDA for brimonidine tartrate ophthalmic solution, 0.025% and set a PDUFA action date of December 27, 2017 Source text for Eikon: Further company coverage:
UPDATE 1-Property markets outlook remains strong as golden age fades -PGIM
NEW YORK, June 27 A golden period in global property markets appears near an end as rising interest rates and lower returns hurt performance, but the outlook for real estate remains strong, asset manager PGIM said on Tuesday.